# Neurosurgical management of pineal lesions: Insights from a single-center study of 27 cases

**Authors:** David Montesinos Contreras, Walter Stummer, Maryam Khaleghi Ghadiri

PMC · DOI: 10.37796/2211-8039.1700 · BioMedicine · 2026-03-01

## TL;DR

This study examines surgical outcomes for 27 patients with pineal lesions, finding that total tumor resection may reduce recurrence risk and improve survival.

## Contribution

The study provides insights into the impact of surgical approaches and resection extent on outcomes for pineal lesions.

## Key findings

- Total resection is associated with reduced tumor recurrence risk.
- Histological subtype significantly predicts progression-free survival.
- Greater resection extent may improve long-term outcomes when safely feasible.

## Abstract

Pineal lesions are rare and surgically challenging due to their deep location, histological diversity, and potential malignancy. The complexity of the pineal region anatomy and the diverse pathological spectrum contribute to the lack of standardized treatment strategies, making appropriate management controversial.

This study aimed to evaluate the surgical outcomes of patients with pineal tumors or cysts and to assess the impact of different surgical approaches, particularly the extent of resection, on progression-free survival.

We conducted a retrospective analysis of 27 patients treated for pineal tumors or cysts at our institution between 2010 and 2020. Data regarding clinical presentation, surgical technique, extent of resection, pathological diagnosis, and follow-up outcomes were collected and analyzed. Surgical outcomes were compared between patients undergoing biopsy and those receiving varying degrees of tumor resection.

Our analyses suggest that total resection could be the most effective approach for reducing the risk of tumor recurrence. Furthermore, our findings indicate that histological subtype is a statistically significant predictor of progression-free survival in patients.

Our findings suggest that achieving a greater extent of resection, when safely feasible, may contribute to improved long-term outcomes. These results emphasize the need for larger, multicenter studies to further optimize treatment strategies for these complex lesions.

## Full-text entities

- **Genes:** AFP (alpha fetoprotein) [NCBI Gene 174] {aka AFPD, FETA, HPAFP}
- **Diseases:** Parinaud syndrome (MESH:D015835), inflammatory lesion (MESH:D007249), Headaches (MESH:D006261), papilledema (MESH:D010211), metastases (MESH:D009362), glial tumors (MESH:D005910), visual disturbances (MESH:D014786), diplopia (MESH:D004172), hygroma (MESH:D018191), brain disease (MESH:D001927), meningioma (MESH:D008579), back pain (MESH:D001416), dorsal midbrain syndrome (MESH:D020295), germinoma (MESH:D018237), Tumor (MESH:D009369), convergence weakness (MESH:D018908), embryonal carcinomas (MESH:D018236), central nervous system tumors (MESH:D016543), mature teratoma (MESH:D013724), intracranial GCT (MESH:C537296), DM (MESH:D009223), CSF leak (MESH:D065634), haemorrhaged pineal cyst (MESH:D006470), nausea (MESH:D009325), loss of spinal nerve function (MESH:D061227), lamina tecti lesion (MESH:D009059), trochlear nerve palsy (MESH:D020432), fatigue (MESH:D005221), Pineal gland tumors (MESH:D010871), Hydrocephalus (MESH:D006849), neurological disturbances (MESH:D009461), ependymoma (MESH:D004806), GCTs (MESH:D009373), Yolk sac tumors (MESH:D018240), pilocytic astrocytoma (MESH:D001254), Pineal cysts (MESH:D003560), choriocarcinomas (MESH:D002822)
- **Chemicals:** DM (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12962756/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12962756/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC12962756/full.md

---
Source: https://tomesphere.com/paper/PMC12962756